FDA Inspection 1202521 — BioLife Plasma Services LP

BioLife Plasma Services LP — FEI 1937444

The FDA completed an inspection of BioLife Plasma Services LP on April 12, 2023 in Coralville, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 12, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Coralville, IA (United States)